Answers are grounded in this paper and cite their sources.
We report that CD39-expressing-melanoma cells inhibited both T-cell proliferation and the generation of cytotoxic effectors in an adenosine-dependent manner, and that treatment with a CD39-blocking antibody alleviated tumor-mediated immunosuppression. Thus, blocking CD39 ectonucleotidase may represent a novel immunotherapeutic strategy to restore antitumor immunity.
No takes yet. Share an insight, caveat, or question.
Bonnefoy et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: